Showing results (31-40 of 165) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancerAmit Gupta, Pierre I Karakiewicz, Claus G Roehrborn, et al.
Analytical and Quantitative Cytology and Histology|January 24, 2009
Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminologyTheodorus H Van der Kwast, Alexandre R Zlotta, Neil Fleshner, et al.
Urology|March 29, 2014
Lean methodology improves efficiency in outpatient academic uro-oncology clinicsSean C Skeldon, Andrea Simmons, Karen Hersey, et al.
European Urology|November 11, 2017
The Role of Surgery in Metastatic Bladder Cancer: A Systematic ReviewMohammad Abufaraj, Guido Dalbagni, Siamak Daneshmand, et al.
Urology Annals|October 1, 2010
Does nerve-sparing radical prostatectomy increase the risk of positive surgical margins and biochemical progression?Sultan Saud Alkhateeb, Shabbir M Alibhai, Antonio Finelli, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trialBob Djavan, Mesut Remzi, Alexandre R Zlotta, et al.
Clinical Epigenetics|March 29, 2019
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progressionShivani Kamdar, Ruth Isserlin, Theodorus Van der Kwast, et al.
Journal of Clinical Pathology|June 19, 2013
Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinomaMichelle R Downes, Emina E Torlakovic, Najla Aldaoud, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 21, 2024
Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative reviewRui Bernardino, Rashid K Sayyid, Ricardo Leão, et al.
European Urology Focus|July 13, 2023
Long-term Recurrence Rates of Low-risk Non-muscle-invasive Bladder Cancer-How Long Is Cystoscopic Surveillance Necessary?Joshua Ma, Mathieu Roumiguie, Tetsutaro Hayashi, et al.
Pageof 17